Biological markers may add to prediction of outcome achieved by the International Prognostic Score in Hodgkin's disease.

@article{Axdorph2000BiologicalMM,
  title={Biological markers may add to prediction of outcome achieved by the International Prognostic Score in Hodgkin's disease.},
  author={Ulla Axdorph and Jonna Sj{\"o}berg and Gunnar Grimfors and Ola Landgren and Anna Porwit-Macdonald and Magnus Bj{\"o}rkholm},
  journal={Annals of oncology : official journal of the European Society for Medical Oncology},
  year={2000},
  volume={11 11},
  pages={1405-11}
}
BACKGROUND The International Prognostic Score (IPS) identifies seven independent factors predicting progression-free and overall survival in advanced stage Hodgkin's disease (HD). The IPS is also applicable in limited disease. However, the IPS does not identify patients with a very poor prognosis. The aim of this study was to define biological markers which may add to the IPS in predicting outcome. PATIENTS AND METHODS One hundred forty-five patients (> 15 years) with HD of all stages and… CONTINUE READING